← Back to Search

Virus Therapy

IMC-1 for Fibromyalgia (FORTRESS Trial)

Phase 2
Waitlist Available
Research Sponsored by Virios Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The patient is female, 18 to 65 years of age, inclusive.
The in clinic 7-day recall VAS scale average daily pain intensity score at Screening visit within protocol defined range.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 week
Awards & highlights

FORTRESS Trial Summary

This trial tested if a drug was safe and effective in treating people with fibromyalgia.

Eligible Conditions
  • Fibromyalgia

FORTRESS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
The patient is a woman, between the ages of 18 and 65.
Select...
At the Screening visit, the average pain intensity score on the 7-day recall VAS scale was within the protocol-defined range.

FORTRESS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean Pain Score

FORTRESS Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: IMC-1 Oral TabletExperimental Treatment1 Intervention
2X IMC-1 Tablet taken orally, each morning and evening.
Group II: PlaceboPlacebo Group1 Intervention
2X Placebo Tablet taken orally, each morning and evening.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
IMC-1
2021
Completed Phase 2
~570

Find a Location

Who is running the clinical trial?

Virios Therapeutics, Inc.Lead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Washington
Massachusetts
Texas
Other
How old are they?
18 - 65
What site did they apply to?
IMC Study Site
Other
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

None of the standard of care medications have helped me. I'm hoping that this trial might help me get relief while benefitting the future of treatment.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1
2021. "Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04748705.
~110 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top